USA TODAY on MSN10d
Here's why researchers think most people stop taking weight loss drugs within a yearNearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...
A small semaglutide trial suggests the medicine's suppression of appetite may extend to alcohol, but larger tests are needed ...
News Medical on MSN10d
Prescription trends for obesity medications surge, tied to growing interest in GLP-1 drugsObesity medication prescriptions reached 1.5 million, driven by GLP-1 agents semaglutide and tirzepatide, as public interest ...
They include semaglutide (Wegovy), liraglutide (Saxenda), and tirzepatide (Zepbound). GLP-1 receptor agonists can increase satiety, reduce appetite, and regulate blood sugar levels — all of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results